| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 743434 | 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one | 0.00126952303154154 | 0.34348968 |
| NSC 382049 | 2,4-Pyrimidinediamine, 6-ethyl-5-[3-nitro- 4-[(2-phenylethyl)amino]phenyl]- | 0.00160168059169488 | 0.41132641 |
| NSC 626878 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride | 0.00160168059169488 | 0.35739537 |
| NSC 637507 | Null | 0.00160168059169488 | 0.569343 |
| NSC 643486 | Null | 0.00160168059169488 | 0.37204511 |
| NSC 643740 | Null | 0.00160168059169488 | 0.40840829 |
| NSC 643827 | 2-Propanol, 3-methoxy-1-[methyl(octadecyl)amino]-, dihydrogen phosphate, monoester with choline hydroxide,inner salt | 0.00160168059169488 | 0.24403981 |
| NSC 698960 | Null | 0.00160168059169488 | 0.35514517 |
| NSC 747451 | 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide | 0.0016016805916949 | 0.55475016 |
| NSC 174121 | Methotrexate Derivative | 0.0016656119381614 | 0.40088146 |